Tenax Therapeutics, Inc. (TENX) Financials

TENX Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 11.9 million 602214
2023-06-30 14.0 million 823841
2023-03-31 15.3 million 993861
2022-12-31 3.4 million 1.9 million

TENX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -2.1 million ?
2023-06-30 -922966 50
2023-03-31 -1.7 million 66
2022-12-31 -2.3 million 85

TENX Net Income

No data available :(

TENX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 11.1 million - -
2023-06-30 13.4 million - -
2023-03-31 14.4 million - -
2022-12-31 2.1 million - 183589

TENX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 23.9 million
2023-06-30 22.1 million
2023-03-31 9.3 million
2022-12-31 1.5 million

TENX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 1.1 million 1.1 million -
2023-06-30 - 197903 1.0 million -
2023-03-31 1241 265735 1.3 million -
2022-12-31 2323 1.1 million 1.4 million -

TENX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 1000
2023-06-30 - 1000
2023-03-31 - 895
2022-12-31 - 29202

TENX

Price: $3.53

52 week price:
3.47
61.20

Earnings Per Share: -31.04 USD

P/E Ratio: -0.10

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 57000

Ebitda: -44.8 million

Market Capitalization: 7.5 million

Links: